Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: A report of three cases in Guangdong, China

Mycoses

Volumn 52, Issue 2, 2009, Pages 176-181

  Zhang, Junmin ^a   Xi, Liyan ^a   Lu, Changming ^a   Li, Xiqing ^a   Xie, Ting ^a   Zhang, Hui ^a   Xie, Zhi ^a   Sybren, De Hoog ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

Chromoblastomycosis; Fonsecaea monophora; Itraconazole; Terbinafine

Indexed keywords

HERBACEOUS AGENT; ITRACONAZOLE; STEROID; TERBINAFINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CHINA; CHINESE HERB; CHROMOMYCOSIS; DNA SEQUENCE; DRUG TREATMENT FAILURE; ERYTHEMA; FACE; FONSECAEA; FONSECAEA MONOPHORA; HUMAN; HUMAN TISSUE; LEG; LIVER TOXICITY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PRURITUS; SKIN NODULE; STEROID THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIFUNGAL AGENTS; ASCOMYCOTA; CHINA; CHROMOBLASTOMYCOSIS; DRUG THERAPY, COMBINATION; FACE; HUMANS; ITRACONAZOLE; LEG DERMATOSES; MALE; MIDDLE AGED; NAPHTHALENES; TREATMENT OUTCOME;

FONSECAEA MONOPHORA; FONSECAEA PEDROSOI;

EID: 59149104762     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01547.x     Document Type: Article

References (25)

1. Hamza SH, Mercado PJ, Skelton HG, Smith KJ. An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature. J Cutan Pathol 2003 30 : 340 3.
2. Minotto R, Bernardi CD, Mallmann LF, Edelweiss MI, Scroferneker ML. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol 2001 44 : 585 92.
3. Dixon DM, Polak-Wyss A. The medically important dematiaceous fungi and their identification. Mycoses 1991 34 : 1 18.
4. Brand ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother 2003 15 (Suppl. 2 36 47.
5. Park SG, Oh SH, Suh SB, Lee KH, Chung KY. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine. Br J Dermatol 2005 152 : 560 4.
6. Lopez Martinez R, Mendez Tovar LJ. Chromoblastomycosis. Clin Dermatol 2007 25 : 188 94.
7. Xianyi Z, Abliz P, Takizawa K, Liyan X. Chromomycosis caused by Phialophora verrucosa, a case report, and ubiquinone system and DNA sequence analysis of pathogen. Chin J Dermatol 2005 38 : 112 4.
8. Lijie Q, Li L, Qiangqiang Z. A case of chromomycosis caused by Phialophora verrucosa. Chin J Derm Venereol 2005 19 : 556 7.
9. Chunyang L, Quande Y. Five cases of chromoblastomycosis cured with itraconazole. J Clin Dermatol 2000 29 : 352.
10. Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother 2006 50 : 96 103.
11. De Hoog GS, Attili-Angelis D, Vicente VA, Van Den Ende AH, Queiroz-Telles F. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 2004 42 : 405 16.
12. Surash S, Tyagi A, De Hoog GS, Zeng JS, Barton RC, Hobson RP. Cerebral phaeohyphomycosis caused by Fonsecaea monophora. Med Mycol 2005 43 : 465 72.
13. Meletiadis J, Mouton JW, Rodriguez-Tudela JL, Meis JF, Verweij PE. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother 2000 44 : 470 2.
14. De Hoog GS, Queiroz-Telles F, Haase G et al. Black fungi: clinical and pathogenic approaches. Med Mycol 2000 38 : 243 50.
15. Elgart GW. Chromoblastomycosis. Dermatol Clin 1996 14 : 77 83.
16. Milam CP, Fenske NA. Chromoblastomycosis. Dermatol Clin 1989 7 : 219 25.
17. Andrade TS, Castro LG, Nunes RS, Gimenes VM, Cury AE. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 2004 47 : 216 21.
18. Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 1987 9 (Suppl. 1 S57 63.
19. Esterre P, Inzan CK, Ramarcel ER et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996 134 (Suppl. 46 33 36.
20. Queiroz-Telles F, Purim KS, Fillus JN et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 1992 31 : 805 12.
21. Xibao Z, Changxing L, Quan L, Yuqing H. Treatment of chromoblastomycosis with terbinafine: a report of four cases. J Dermatolog Treat 2005 16 : 121 4.
22. Gupta AK, Taborda PR, Sanzovo AD. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol 2002 40 : 529 34.
23. Barchiesi F, Falconi Di Francesco L, Scalise G. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrob Agents Chemother 1997 41 : 1812 4.
24. Shenep JL, English BK, Kaufman L et al. Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child. Clin Infect Dis 1998 27 : 1388 93.
25. Ryder NS, Leitner I. Synergistic interactions of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol 2001 39 : 91 95.